14-3-3 mediated regulation of the tumor suppressor protein, RASSF1A

Haya Abu Ghazaleh1, Renfred S Chow, Sheryl L Choo

  • 1Department of Pediatrics, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, AB T6G 2N8, Canada.

Insights

Ras association domain family protein 1A (RASSF1A) tumor suppressor function in apoptosis is regulated by 14-3-3 protein binding. Loss of this binding initiates RASSF1A-mediated cell death, revealing a key control mechanism.

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Biochemistry

Background:

  • Death receptor-mediated apoptosis is crucial for controlling cell growth.
  • Ras association domain family protein 1A (RASSF1A) acts as a tumor suppressor in this process.
  • The precise initiation mechanism of RASSF1A-mediated cell death remained unclear.

Purpose of the Study:

  • To elucidate the role of 14-3-3 proteins in regulating RASSF1A-mediated apoptosis.
  • To identify the specific interactions and signaling events involved in RASSF1A-mediated cell death initiation.
  • To investigate the impact of RASSF1A phosphorylation on its interaction with 14-3-3 and subsequent cell death.

Main Methods:

  • Utilized tumor necrosis factor alpha (TNFα) and TNFα-related apoptosis-inducing ligand (TRAIL) stimulation to trigger apoptosis.
  • Investigated protein-protein interactions using co-immunoprecipitation assays.
  • Employed site-directed mutagenesis to alter phosphorylation sites on RASSF1A.
  • Assessed cell death markers, including Annexin V staining and poly (ADP-ribose) polymerase (PARP) cleavage.

Main Results:

  • Basal association of RASSF1A with 14-3-3 proteins was disrupted upon TNFα or TRAIL stimulation.
  • Disruption of 14-3-3 binding led to RASSF1A association with modulator of apoptosis 1 (MOAP-1) and death receptors (TNF-R1/TRAIL-R1).
  • Phosphorylation of RASSF1A by glycogen synthase kinase 3β (GSK-3β) at serine residues 175, 178, and 179 is essential for 14-3-3 binding.
  • Mutating these serine residues resulted in premature RASSF1A recruitment to MOAP-1 and death receptors, and increased basal cell death and apoptosis markers upon TNFα stimulation.

Conclusions:

  • 14-3-3 proteins act as critical negative regulators of RASSF1A-mediated apoptosis.
  • The phosphorylation status of RASSF1A dictates its interaction with 14-3-3 proteins, thereby controlling the initiation of cell death.
  • This study reveals a novel regulatory mechanism for RASSF1A-mediated cell death, highlighting the importance of 14-3-3 binding in tumor suppression.

Related Concept Videos

The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
Small GTPases - Ras and Rho01:24

Small GTPases - Ras and Rho

Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity: